本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

166.05
+1.400.85%
盘前166.050.00000.00%06:36 EDT
成交量:31.56万
成交额:5,190.67万
市值:99.37亿
市盈率:-24.56
高:166.86
开:164.29
低:161.01
收:164.65
数据加载中...

公司资料

公司名字:
Ascendis Pharma A/S
交易所:
NASDAQ
成立时间:
2006
员工人数:
1017
公司地址:
Tuborg Boulevard 12,Hellerup,Capital Region of Denmark,Denmark
邮编:
2900
传真:
- -
简介:
Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司,该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品,TransCon人生长激素或生长激素TransCon,每周一次给药治疗生长激素缺乏症以及其他疾病。

董事

名称
职位
Jan Moller Mikkelsen
President, Chief Executive Officer, Board Member and Executive Director
Michael Wolff Jensen
Chairman and Senior Vice President, Chief Legal Officer
Albert Cha
Director
Birgitte Volck
Director
James I. Healy
Director
Lars Holtug
Director
Lisa Bright
Director

股东

名称
职位
Jan Moller Mikkelsen
President, Chief Executive Officer, Board Member and Executive Director
Dana Pizzuti
Senior Vice President, Development Operations
Flemming Steen Jensen
Senior Vice President, Product Supply
Jens Sigurd Okkels
Senior Vice President, Product Development
Jesper Hoiland
Senior Vice President, Global Chief Commercial Officer
Juha Punnonen
Senior Vice President, Head of Oncology
Kennett Sprogoe
Senior Vice President, Head of Innovation and Research
Lotte Sonderbjerg
Senior Vice President, Chief Administrative Officer
Mark Bach
Senior Vice President, Clinical Development and Medical Affairs for Endocrine Medical Sciences
Michael Wolff Jensen
Chairman and Senior Vice President, Chief Legal Officer
Scott T. Smith
Senior Vice President, Chief Financial Officer
Vibeke Miller Breinholt
Senior Vice President, Nonclinical Development and Bioanalysis
Peter Rasmussen
Vice President, Finance and Principal Accounting Officer